Professor Michael Heinrich (UCL School of Pharmacy) comments in an article on the general safety of CBD. He explains that, despite few reported unwanted outcomes, the unregulated CBD market meant reporting of unforeseen effects was very unlikely.
Read: Telegraph (£)
Close
